TELO
Telomir Pharmaceuticals, Inc. Common StockstockNASDAQ
Market OpenNov 19, 2026 3:25:16 PM EST
0.43USD+2.521%(+0.01)236,061
Pre-marketNov 19, 2026 8:59:30 AM EST
0.4754USD+13.056%(+0.0549)
TELO Financials
In Q3 FY 2026 (ended ), Telomir Pharmaceuticals, Inc. Common Stock (TELO) reported revenue of $0, net income of −$705.23K, operating cash flow of −$586.44K, and assets of $4.64M (filed ).
Loading financial statements…